Intervention Review

Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants

  1. Peter W Fowlie1,*,
  2. Peter G Davis2,
  3. William McGuire3

Editorial Group: Cochrane Neonatal Group

Published Online: 7 JUL 2010

Assessed as up-to-date: 19 MAY 2010

DOI: 10.1002/14651858.CD000174.pub2


How to Cite

Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD000174. DOI: 10.1002/14651858.CD000174.pub2.

Author Information

  1. 1

    Ninewells Hospital and Medical School, Women & Child Health, Dundee, Scotland, UK

  2. 2

    The Royal Women's Hospital, Department of Newborn Research, Parkville, Victoria, Australia

  3. 3

    Hull York Medical School, Centre for Reviews and Dissemination, York, Y010 5DD, UK

*Peter W Fowlie, Women & Child Health, Ninewells Hospital and Medical School, Dundee, Scotland, DD1 9SY, UK. peter.fowlie@nhs.net.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 JUL 2010

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sarah Lai, Weiming Yu, Laurie Wallace, David Sigalet, Intestinal muscularis propria increases in thickness with corrected gestational age and is focally attenuated in patients with isolated intestinal perforations, Journal of Pediatric Surgery, 2014, 49, 1, 114

    CrossRef

  2. 2
    Keith J. Barrington, Management during the first 72h of age of the periviable infant: An evidence-based review, Seminars in Perinatology, 2014, 38, 1, 17

    CrossRef

  3. 3
    Praveen Ballabh, Pathogenesis and Prevention of Intraventricular Hemorrhage, Clinics in Perinatology, 2014, 41, 1, 47

    CrossRef

  4. 4
    Catherine L. Webb, Carol L. Waugh, Jim Grigsby, David Busenbark, Kaliope Berdusis, David J. Sahn, Craig A. Sable, Impact of Telemedicine on Hospital Transport, Length of Stay, and Medical Outcomes in Infants with Suspected Heart Disease: A Multicenter Study, Journal of the American Society of Echocardiography, 2013, 26, 9, 1090

    CrossRef

  5. 5
    Souvik Mitra, Arild Rønnestad, Henrik Holmstrøm, Management of Patent Ductus Arteriosus in Preterm Infants—Where Do We Stand?, Congenital Heart Disease, 2013, 8, 6
  6. 6
    Dan L. Ellsbury, Robert Ursprung, A Quality Improvement Approach to Optimizing Medication Use in the Neonatal Intensive Care Unit, Clinics in Perinatology, 2012, 39, 1, 1

    CrossRef

  7. 7
    Nick Evans, Diagnosis of the Preterm Patent Ductus Arteriosus: Clinical Signs, Biomarkers, or Ultrasound?, Seminars in Perinatology, 2012, 36, 2, 114

    CrossRef

  8. 8
    Palmer G. Johnston, Maria Gillam-Krakauer, M. Paige Fuller, Jeff Reese, Evidence-Based Use of Indomethacin and Ibuprofen in the Neonatal Intensive Care Unit, Clinics in Perinatology, 2012, 39, 1, 111

    CrossRef

  9. 9
    Cathy Hammerman, Alona Bin-Nun, Michael Kaplan, Managing the Patent Ductus Arteriosus in the Premature Neonate: A New Look at What We Thought We Knew, Seminars in Perinatology, 2012, 36, 2, 130

    CrossRef

  10. 10
    Ronald I. Clyman, James Couto, Gail M. Murphy, Patent Ductus Arteriosus: Are Current Neonatal Treatment Options Better or Worse Than No Treatment at All?, Seminars in Perinatology, 2012, 36, 2, 123

    CrossRef

  11. 11
    Andrew Whitelaw, Periventricular hemorrhage: A problem still today, Early Human Development, 2012, 88, 12, 965

    CrossRef

  12. 12
    Nick Evans, Preterm patent ductus arteriosus: Should we treat it?, Journal of Paediatrics and Child Health, 2012, 48, 9
  13. You have free access to this content13
    Inge Zonnenberg, Koert de Waal, The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review, Acta Paediatrica, 2012, 101, 3
  14. 14
    Ronald Clyman, Shahab Noori, Hemodynamics and Cardiology: Neonatology Questions and Controversies, 2012,

    CrossRef

  15. 15
    Karl G. Sylvester, Gigi Y. Liu, Craig T. Albanese, Pediatric Surgery, 2012,

    CrossRef

  16. 16
    K AlFaleh, Indomethacin prophylaxis revisited: changing practice and supportive evidence, Acta Paediatrica, 2011, 100, 5
  17. 17
    Nick Evans, Management of the patent ductus arteriosus in the very pre-term infant, Paediatrics and Child Health, 2011, 21, 6, 247

    CrossRef

  18. 18
    Jasim Anabrees, Khalid AlFaleh, Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants, The Cochrane Library,
  19. 19
    Arne Ohlsson, Sachin S Shah, Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants, The Cochrane Library,
  20. 20
    Arne Ohlsson, Rajneesh Walia, Sachin S Shah, Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants, The Cochrane Library,
  21. 21
    Arne Ohlsson, Rajneesh Walia, Sachin S Shah, Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants, The Cochrane Library,
  22. 22
    Arne Ohlsson, Prakeshkumar S Shah, Paracetamol (acetaminophen) for patent ductus arteriosus in preterm and/or low-birth-weight infants, The Cochrane Library,
  23. 23
    Arne Ohlsson, Prakeshkumar S Shah, Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants, The Cochrane Library,